EquityFocused FundVery High Risk
Direct
NAV (12-Sep-25)
Returns (Since Inception)
Fund Size
₹1,919 Cr
Expense Ratio
0.80%
ISIN
INF194K01W21
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
01 Jan 2013
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+1.56%
— (Cat Avg.)
3 Years
+18.46%
+15.67% (Cat Avg.)
5 Years
+18.76%
+20.08% (Cat Avg.)
10 Years
+14.78%
+14.18% (Cat Avg.)
Since Inception
+13.76%
— (Cat Avg.)
Equity | ₹1,818.19 Cr | 94.73% |
Others | ₹101.2 Cr | 5.27% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Power Finance Corp Ltd | Equity | ₹154.26 Cr | 8.04% |
State Bank of India | Equity | ₹150.54 Cr | 7.84% |
HDFC Bank Ltd | Equity | ₹123.97 Cr | 6.46% |
ICICI Bank Ltd | Equity | ₹99.33 Cr | 5.17% |
Triparty Repo Trp_010925 | Cash - Repurchase Agreement | ₹97.62 Cr | 5.09% |
Prestige Estates Projects Ltd | Equity | ₹94.01 Cr | 4.90% |
One97 Communications Ltd | Equity | ₹73.67 Cr | 3.84% |
Cholamandalam Financial Holdings Ltd | Equity | ₹71.5 Cr | 3.73% |
Larsen & Toubro Ltd | Equity | ₹68.84 Cr | 3.59% |
LT Foods Ltd | Equity | ₹66.06 Cr | 3.44% |
Infosys Ltd | Equity | ₹64.71 Cr | 3.37% |
The South Indian Bank Ltd | Equity | ₹62.98 Cr | 3.28% |
Jubilant Pharmova Ltd | Equity | ₹61.16 Cr | 3.19% |
ITC Ltd | Equity | ₹58.66 Cr | 3.06% |
Deepak Fertilisers & Petrochemicals Corp Ltd | Equity | ₹56.92 Cr | 2.97% |
Varun Beverages Ltd | Equity | ₹55.21 Cr | 2.88% |
NTPC Ltd | Equity | ₹50.61 Cr | 2.64% |
Eternal Ltd | Equity | ₹50.55 Cr | 2.63% |
Mankind Pharma Ltd | Equity | ₹49.45 Cr | 2.58% |
Signatureglobal (India) Ltd | Equity | ₹48.47 Cr | 2.53% |
Reliance Industries Ltd | Equity | ₹48.43 Cr | 2.52% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹47.28 Cr | 2.46% |
Glenmark Pharmaceuticals Ltd | Equity | ₹44.02 Cr | 2.29% |
Bharti Airtel Ltd | Equity | ₹43.44 Cr | 2.26% |
Tata Consultancy Services Ltd | Equity | ₹42.09 Cr | 2.19% |
Aurobindo Pharma Ltd | Equity | ₹40.81 Cr | 2.13% |
Sanathan Textiles Ltd | Equity | ₹38.18 Cr | 1.99% |
Angel One Ltd Ordinary Shares | Equity | ₹29.73 Cr | 1.55% |
E2E Networks Ltd Ordinary Shares | Equity | ₹16.68 Cr | 0.87% |
Tilaknagar Industries Ltd | Equity | ₹6.63 Cr | 0.35% |
Cash Margin - Derivatives | Cash - Collateral | ₹2 Cr | 0.10% |
Net Receivables/Payables | Cash - Collateral | ₹0.74 Cr | 0.04% |
Cash Margin - Ccil | Cash - Repurchase Agreement | ₹0.54 Cr | 0.03% |
Cash / Bank Balance | Cash - Collateral | ₹0.29 Cr | 0.02% |
Large Cap Stocks
55.23%
Mid Cap Stocks
16.88%
Small Cap Stocks
22.62%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Financial Services | ₹692.32 Cr | 36.07% |
Healthcare | ₹242.72 Cr | 12.65% |
Technology | ₹197.15 Cr | 10.27% |
Consumer Defensive | ₹186.56 Cr | 9.72% |
Real Estate | ₹142.48 Cr | 7.42% |
Consumer Cyclical | ₹88.72 Cr | 4.62% |
Industrials | ₹68.84 Cr | 3.59% |
Basic Materials | ₹56.92 Cr | 2.97% |
Utilities | ₹50.61 Cr | 2.64% |
Energy | ₹48.43 Cr | 2.52% |
Communication Services | ₹43.44 Cr | 2.26% |
Standard Deviation
This fund
14.09%
Cat. avg.
13.23%
Lower the better
Sharpe Ratio
This fund
0.78
Cat. avg.
0.66
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.10
Higher the better
Since December 2024
Since December 2024
Since October 2023
Since June 2024
Since December 2024
ISIN INF194K01W21 | Expense Ratio 0.80% | Exit Load 1.00% | Fund Size ₹1,919 Cr | Age 12 years 8 months | Lumpsum Minimum ₹1,000 | Fund Status Open Ended Investment Company | Benchmark BSE 500 India TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹1,83,484 Cr
Address
6th Floor, 841, One World Center, Mumbai, 400013
Your principal amount will be at Very High Risk
EquityFocused FundVery High Risk
Direct
NAV (12-Sep-25)
Returns (Since Inception)
Fund Size
₹1,919 Cr
Expense Ratio
0.80%
ISIN
INF194K01W21
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
01 Jan 2013
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+1.56%
— (Cat Avg.)
3 Years
+18.46%
+15.67% (Cat Avg.)
5 Years
+18.76%
+20.08% (Cat Avg.)
10 Years
+14.78%
+14.18% (Cat Avg.)
Since Inception
+13.76%
— (Cat Avg.)
Equity | ₹1,818.19 Cr | 94.73% |
Others | ₹101.2 Cr | 5.27% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Power Finance Corp Ltd | Equity | ₹154.26 Cr | 8.04% |
State Bank of India | Equity | ₹150.54 Cr | 7.84% |
HDFC Bank Ltd | Equity | ₹123.97 Cr | 6.46% |
ICICI Bank Ltd | Equity | ₹99.33 Cr | 5.17% |
Triparty Repo Trp_010925 | Cash - Repurchase Agreement | ₹97.62 Cr | 5.09% |
Prestige Estates Projects Ltd | Equity | ₹94.01 Cr | 4.90% |
One97 Communications Ltd | Equity | ₹73.67 Cr | 3.84% |
Cholamandalam Financial Holdings Ltd | Equity | ₹71.5 Cr | 3.73% |
Larsen & Toubro Ltd | Equity | ₹68.84 Cr | 3.59% |
LT Foods Ltd | Equity | ₹66.06 Cr | 3.44% |
Infosys Ltd | Equity | ₹64.71 Cr | 3.37% |
The South Indian Bank Ltd | Equity | ₹62.98 Cr | 3.28% |
Jubilant Pharmova Ltd | Equity | ₹61.16 Cr | 3.19% |
ITC Ltd | Equity | ₹58.66 Cr | 3.06% |
Deepak Fertilisers & Petrochemicals Corp Ltd | Equity | ₹56.92 Cr | 2.97% |
Varun Beverages Ltd | Equity | ₹55.21 Cr | 2.88% |
NTPC Ltd | Equity | ₹50.61 Cr | 2.64% |
Eternal Ltd | Equity | ₹50.55 Cr | 2.63% |
Mankind Pharma Ltd | Equity | ₹49.45 Cr | 2.58% |
Signatureglobal (India) Ltd | Equity | ₹48.47 Cr | 2.53% |
Reliance Industries Ltd | Equity | ₹48.43 Cr | 2.52% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹47.28 Cr | 2.46% |
Glenmark Pharmaceuticals Ltd | Equity | ₹44.02 Cr | 2.29% |
Bharti Airtel Ltd | Equity | ₹43.44 Cr | 2.26% |
Tata Consultancy Services Ltd | Equity | ₹42.09 Cr | 2.19% |
Aurobindo Pharma Ltd | Equity | ₹40.81 Cr | 2.13% |
Sanathan Textiles Ltd | Equity | ₹38.18 Cr | 1.99% |
Angel One Ltd Ordinary Shares | Equity | ₹29.73 Cr | 1.55% |
E2E Networks Ltd Ordinary Shares | Equity | ₹16.68 Cr | 0.87% |
Tilaknagar Industries Ltd | Equity | ₹6.63 Cr | 0.35% |
Cash Margin - Derivatives | Cash - Collateral | ₹2 Cr | 0.10% |
Net Receivables/Payables | Cash - Collateral | ₹0.74 Cr | 0.04% |
Cash Margin - Ccil | Cash - Repurchase Agreement | ₹0.54 Cr | 0.03% |
Cash / Bank Balance | Cash - Collateral | ₹0.29 Cr | 0.02% |
Large Cap Stocks
55.23%
Mid Cap Stocks
16.88%
Small Cap Stocks
22.62%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Financial Services | ₹692.32 Cr | 36.07% |
Healthcare | ₹242.72 Cr | 12.65% |
Technology | ₹197.15 Cr | 10.27% |
Consumer Defensive | ₹186.56 Cr | 9.72% |
Real Estate | ₹142.48 Cr | 7.42% |
Consumer Cyclical | ₹88.72 Cr | 4.62% |
Industrials | ₹68.84 Cr | 3.59% |
Basic Materials | ₹56.92 Cr | 2.97% |
Utilities | ₹50.61 Cr | 2.64% |
Energy | ₹48.43 Cr | 2.52% |
Communication Services | ₹43.44 Cr | 2.26% |
Standard Deviation
This fund
14.09%
Cat. avg.
13.23%
Lower the better
Sharpe Ratio
This fund
0.78
Cat. avg.
0.66
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.10
Higher the better
Since December 2024
Since December 2024
Since October 2023
Since June 2024
Since December 2024
ISIN INF194K01W21 | Expense Ratio 0.80% | Exit Load 1.00% | Fund Size ₹1,919 Cr | Age 12 years 8 months | Lumpsum Minimum ₹1,000 | Fund Status Open Ended Investment Company | Benchmark BSE 500 India TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹1,83,484 Cr
Address
6th Floor, 841, One World Center, Mumbai, 400013
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments